Press release
Chronic Idiopathic Constipation (CIC) Market was valued at USD 8.2 billion in 2024 and is projected to reach USD 12.9 billion by 2034
Chronic Idiopathic Constipation (CIC) Market
The Chronic Idiopathic Constipation (CIC) Market was valued at USD 8.2 billion in 2024 and is projected to reach USD 12.9 billion by 2034, growing at a CAGR of around 4.8%. Growth is driven by rising gastrointestinal disorders, aging population, lifestyle factors, and wider adoption of prescription CIC therapies.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71132
Key Market Drivers
• Increasing prevalence of lifestyle-related constipation and sedentary living.
• Growing use of prescription CIC drugs such as secretagogues and prokinetics.
• Higher diagnosis rates through improved gastroenterology access.
• Strong commercial uptake of branded therapies due to better symptom relief.
Challenges
• High cost of long-term prescription therapy.
• Limited treatment satisfaction among chronic patients.
• High reliance on OTC laxatives reducing prescription uptake in some regions.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/71132/chronic-idiopathic-constipation-market
Market Segmentation
By Treatment
• OTC laxatives (osmotic, stimulant, bulk-forming)
• Prescription therapies (secretagogues, prokinetics)
• Fiber supplements
• Lifestyle modification therapies
By Diagnosis
• Clinical evaluation
• Rome IV criteria
• Colon transit tests
• Imaging and motility studies (select cases)
By End User
• Hospitals
• Gastroenterology clinics
• Retail pharmacies
• Online pharmacies
By Distribution Channel
• Retail pharmacies (largest share)
• Hospital pharmacies
• Online pharmacies
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71132
Regional Snapshot
• North America leads due to high treatment awareness and strong prescription drug adoption.
• Europe shows stable growth with increasing use of advanced therapeutic options.
• Asia-Pacific is the fastest-growing region as gastrointestinal disorder prevalence rises and healthcare access improves.
Key Companies
Ironwood Pharmaceuticals, AbbVie, Takeda, AstraZeneca, Sanofi, Bayer, Bausch Health, Pfizer.
Future Outlook
The CIC market will continue expanding as novel prosecretory drugs, improved prokinetic agents, and personalized GI treatment approaches gain traction. Rising digital GI-health tools and early intervention programs will further support long-term market growth.
This report is also available in the following languages : Japanese (慢性特発性便秘市場), Korean (만성 특발성 변비 시장), Chinese (慢性特发性便秘市场), French (Marché de la constipation chronique idiopathique), German (Markt für chronische idiopathische Verstopfung), and Italian (Mercato della stitichezza cronica idiopatica), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/71132
Our More Reports:
Iron Overload Syndrome Market
https://exactitudeconsultancy.com/reports/70953/iron-overload-syndrome-market
Nausea and Vomiting Induced by Motion Sickness Market
https://exactitudeconsultancy.com/reports/70955/nausea-and-vomiting-induced-by-motion-sickness-market
Palmar Fibromatosis Market
https://exactitudeconsultancy.com/reports/70957/palmar-fibromatosis-market
Perivascular Epithelioid Cell Tumor Market
https://exactitudeconsultancy.com/reports/70959/perivascular-epithelioid-cell-tumor-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Idiopathic Constipation (CIC) Market was valued at USD 8.2 billion in 2024 and is projected to reach USD 12.9 billion by 2034 here
News-ID: 4311715 • Views: …
More Releases from Exactitude Consultancy
Symptomatic Partial-Thickness Rotator Cuff Tears Market is projected to reach US …
The global Symptomatic Partial-Thickness Rotator Cuff Tears (PTRCT) Market was valued at USD 1.64 billion in 2024 and is projected to reach USD 2.95 billion by 2034, growing at a CAGR of 6.1% during 2025-2034. Market expansion is driven by rising sports injuries, increasing prevalence of degenerative shoulder conditions in aging populations, advancements in minimally invasive arthroscopy, and growing adoption of regenerative biologics such as PRP and stem-cell therapies.
Download Full…
Chronic Pancreatitis Market Growing at a CAGR of around 5.6%
Chronic Pancreatitis Market Overview
The Chronic Pancreatitis Market was valued at ~USD 5.1 billion in 2024 and is projected to reach ~USD 8.7 billion by 2034, growing at a CAGR of around 5.6%. Growth is driven by increasing cases of alcohol-related pancreatic injury, lifestyle changes, rising smoking prevalence, and growing demand for enzyme replacement therapies.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71134
Key Market Drivers
• Rising global incidence of alcohol-induced and…
Smoking Cessation Market is projected to reach USD 46.2 billion by 2034
The global Smoking Cessation Market was valued at USD 23.6 billion in 2024 and is projected to reach USD 46.2 billion by 2034, growing at a CAGR of 7.0% during 2025-2034. Rising awareness of smoking-related diseases, growth in government-led tobacco control programs, expanding availability of nicotine-replacement therapies (NRTs), and breakthrough digital and pharmacologic interventions are major factors fueling market growth.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70964
Cigarette smoking…
Medulloblastoma Market at USD 310 million in 2024 and is projected to reach USD …
Medulloblastoma Market
The Medulloblastoma Market was valued at USD 310 million in 2024 and is projected to reach USD 580 million by 2034, growing at a CAGR of around 6.5%. Growth is driven by better survival outcomes through multimodal therapy, improved pediatric oncology infrastructure, and emerging molecular-targeted treatment approaches.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71236
Key Market Drivers
• Rising diagnosis of pediatric and adolescent brain tumors.
• Increased adoption of multimodal treatment: surgery,…
More Releases for CIC
Chronic Idiopathic Constipation (CIC) Market Insights and Future Outlook
Introduction
Chronic Idiopathic Constipation (CIC) is one of the most common functional gastrointestinal disorders, characterized by infrequent bowel movements, straining, and incomplete evacuation. Unlike secondary constipation caused by medications or structural abnormalities, CIC has no identifiable underlying cause, making it a chronic, recurrent condition that impacts millions worldwide. The disorder disproportionately affects women and older adults, significantly reducing quality of life and creating a notable economic burden on healthcare systems.
The global…
IIC And CIC Hearing Aids Market Size Analysis by Application, Type, and Region: …
USA, New Jersey- According to Market Research Intellect, the global IIC And CIC Hearing Aids market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The IIC (Invisible in Canal) and CIC (Completely in Canal) hearing aids market is experiencing steady growth as demand for discreet and…
IIC and CIC Hearing Aids Market Analysis,Demand,Trends and Forecast 2029
Global Info Research announces the release of the report "Global IIC and CIC Hearing Aids Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029" . The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
Complete Exploration & Study on CIC Insurance Group Limited (CIC) Market Size 20 …
CIC Insurance Group Limited (CIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand…
Chronic Idiopathic Constipation (CIC) Treatment Market - Regional Analysis
Regional segmentation of chronic idiopathic constipation treatment market by Coherent Market Insights includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America chronic idiopathic constipation treatment market holds dominant position owing to high percentage of population suffering from chronic constipation. For instance, according to European Journal of Pharmacology, 2017, in the U.S. 12%–19% of population suffers from chronic constipation. This is expected to aid in growth…
Chronic Idiopathic Constipation (CIC) Treatment Market Latest Trends,Analysis & …
Constipation can be defined as reduced stool frequency or difficulty in passing stool. The frequency may be reduced to less than three times a week. Reduced or difficult stool passage includes hard lumpy stools, incomplete bowel movements, straining, incomplete evacuation, and need for manual removal of stool. Chronic idiopathic constipation (CIC) can be defined as more chronic or severe continuation of these above symptoms. Many times the cause of constipation…
